vs 9,062 other HR bills in the 116th — cohort avg 39d
Summary
Support And Value Expectant Moms and Babies Act of 2019 or the SAVE Moms and Babies Act of 2019 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
Lobbying filings that explicitly cite this bill (22)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law.
Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken.
Contacts in support of legislation (not introduced) banning unwanted medical procedures.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections.
Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Council on Disability, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Cited source text, amounts, lobbyists, and targets
Maternal Health Pandemic Response Act (H.R. 8027)
Menstrual Product Right to Know Act (H.R. 2268)
The Heroes Act (H.R. 6800)
A resolution declaring racism a public health crisis. (S. Res. 655)
Expressing the sense of the House that the Department of Justice should defend the Patient Protection and Affordable Care Act (Public Law 111-148; 124 Stat. 119) and halt its efforts to repeal, sabotage, or undermine health care protections for millions of people in the United States in the midst of the public health emergency relating to the Coronavirus Disease 2019 (COVID-19) (H. Res. 1082)
HEALS Act (S. 1624)
Support and Value Expectant Moms and Babies Act (H.R. 4399/S. 3072)
Protect Access to Birth Control Act (H.R. 7517)
Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3)
Prescription Drug Pricing Reduction Act (S. 2543)
Worker Health Coverage Protection Act (H.R. 6514)
Kids' Access to Primary Care Act (H.R. 6159)
Health Care Protection Act (H.R. 6810)
Continuous Health Coverage for Workers Act (S. 4929)
A resolution expressing the sense of the Senate that the Department of Justice should defend the Patient Protection and Affordable Care Act (Public Law 111-148 Stat. 119) and halt its efforts to repeal, sabotage, or undermine health care protections for millions of people in the United States in the midst of the public health emergency relating to the Coronavirus Disease 2019 (COVID-19). (S. Res. 638)
Improving Mental Health Throughout Pregnancy Act (Not yet introduced)
Helping MOMS Act of 2020 (H.R. 4996)
A bill to protect the healthcare of hundreds of millions of people of the United States and prevent efforts of the Department of Justice to advocate courts to strike down the Patient Protection and Affordable Care Act (S. 4653)
A bill to preserve health benefits for workers (S. 4714)
America's Conservation Enhancement Act [The Heroes Act] (H.R. 925)
Client expense: $73,968 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020. Contacts in support of administrative action enforcing existing EMTALA provisions regarding infact treatment and the Born-Alive Infant protection act to the fullest extent possible by law.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Consultations regarding letters of inquiry regarding whether abortion providers have violated various provisions of law regarding human fetal tissue sale or the partial birth abortion ban law.
Contacts regarding a resolution condemning unwanted, unnecessary medical procedures on individuals without their full, informed consent (H. Res. 1154). No position taken.
Contacts in support of legislation (not introduced) banning unwanted medical procedures.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 2694). No position taken.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Contacts in opposition to the HEROES Act 2.0, which contains numerous provisions that permit funds to flow to the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections.
Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Client expense: $126,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Council on Disability, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to enforce REMS during Covid-19 pandemic.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Contacts in opposition to H.R. 6800 (HEROS Act), which contains numerous provisions aimed at propping up the abortion industry as well as potentially funneling millions of dollars into programs without Hyde protections; letter to the House dated May 15, 2020.
Contacts in support of H.R. 6742, the Protecting Life in Crisis Act which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Client expense: $80,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Cited source text, amounts, lobbyists, and targets
H.R. 4399/S.3072: Support and Value Moms and Babies Act; H.R. 748/S. 3548: CARES Act; H.R. 6201: Families First Coronavirus Response Act; Motion to Recommit to H.R. 535: PFAS Action Act; Bioethics issues
Client expense: $230,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4399/S.3072: Support and Value Moms and Babies Act; Defunding abortion providers; Motion to Recommit to H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act; H.R. 6201: Families First Coronavirus Response Act; H.R. 748/S. 3548: CARES Act.
Client expense: $230,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 748/S. 3548: CARES Act; H.R. 6201: Families First Coronavirus Response Act; Motion to Recommit to H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act; H.R. 4399/S.3072: Support and Value Moms and Babies Act; Bioethics issues; S. 160: Pain-Capable Unborn Child Protection Act; S. 130: Born-Alive Abortion Survivors Protection Act; Temporary Assistance for Needy Families.
Client expense: $230,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4399/S.3072: Support and Value Moms and Babies Act; H.R. 1980: Women's History Museum; Affordable Care Act enforcement, Abortion separate payments; H.J.Res. 79: Equal Rights Amendment; Bioethics issues; S.160: Pain-Capable Unborn Child Protection Act; Temporary Assistance for Needy Families; Defunding abortion providers; S. 130: Born-Alive Abortion Survivors Protection Act; Motion to Recommit to H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act; Motion to Recommit to H.R. 535: PFAS Action Act; H.R. 6201: Families First Coronavirus Response Act; H.R. 748/S. 3548: CARES Act
Client expense: $230,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age including a letter to the Senate dated February 21, 2020.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Letter sent to the House dated February 28, 2020 on a Motion to Recommit. Letter sent to the Senate dated Febuary 21, 2020.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions.
Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law. Additional urging to not roll back REMS during Covid-19 pandemic.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of life-sustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Sanctity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts urging HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of the Womens Right to Know Act (H.R. 6077/S. 3388) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 160/H.R. 784), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Save Our Children Act of 2019 (H.R. 956) to ban dismemberment abortions and the Dismemberment Abortion Ban Act (S. 1035), to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (S. 182/ H.R.2373 ) to prohibit discrimination against the unborn on the basis of sex.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 962/S. 311/S.130), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.109/H.R. 20) to codify government-wide policy against funding abortion.
Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 119/ H.R.611), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions.
Contacts in support of Child Custody Protection Act S.194/ H.R.2817), to prohibit transporting a minor across a state line to obtain an abortion without satisfying a parental involvement law in the minor's resident state.
Contacts in support of the Conscience Protection Act (H.R. 2014/S.183), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion.
Contacts regarding legislation to defund certain abortion providers (S. 141/H.R. 369/S.1966/H.R.833) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts in support of the Title X Abortion Provider Prohibition Act (S. 105/H.R. 296) to make abortion providers ineligible to receive Title X family planning funds.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding legislation to improve abortion reporting (S.2585/H.R.3580 and others not introduced).
Contacts in response to inquiries regarding the Heartbeat Bill (H.R. 490) and similar legislation not introduced to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter.
Contacts in opposition to "EACH Woman Act" (H.R. 1692/S. 758), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans."
Contacts in support of the Second Chance at Life Act (H.R. 2010) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Responses to inquiries regarding the Ultrasound Informed Consent Act (H.R. 634), which provides that prior to an abortion, a provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting and display the ultrasound images so that the pregnant woman may view them.
Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law.
Contacts in support of Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 4934/ H.R. 671/S.2590).
Contacts in support of agency action strengthening regulation surrounding the use of mifepristone and RU-486 to the extent permitted by law.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.2754/ H.R.4903 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2019 (S.3072 /H.R. 4399) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts regarding the Parental Accessibility Rights for Emergency and Negligent Treatment Act (S.3138) to require any healthcare facility that receives Medicaid or CHIP funds to make public their policies related to the provision, withdrawal, or denial of lifesustaining procedures, nutrition, or medication, policies related to parental consent of these services, and policies related to the required notification of parents and parental consent for a do-not-resuscitate order.
Contacts in support of the Teleabortion Prevention Act of 2019 (H.R.4935) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts regarding the Parental Right to Know Act (S.3137) to require any healthcare facility that receives Medicaid or CHIP funds to include the information on parental access to medical records of minors under the age of 18 on their website and in print, upon request of the patient or parent.
Contacts explaining nonsupport for the Life at Conception Act (S.159/H.R. 616) and the Santity of Human Life Act (H.R. 305) based on lack of clarity and erroneous legal premises.
Contacts in support of the Equal Right to Life Act (H.R.4442) to prohibit the prenatal genetic testing or abortion of an unborn child on the basis of the childs presumed sexual orientation.
Contacts regarding the Patients First Act of 2019 (S.2308 /H.R.64) to direct HHS to prioritize stem cell research that has the best chance of producing near-term benefits in treatments for patients, without the creation, destruction, or risk of injury to human embryos.
Contacts in support of enforcement of numerous federal statues as they relate to the conscience protection rights of those not willing to participate in, refer, or pay for abortion.
Cited source text, amounts, lobbyists, and targets
H.R. 4399/S.3072: Support and Value Moms and Babies Act; H.R. 2500/S. 1790: National Defense Authorization Act for Fiscal Year 2020; H.R. 962/S. 130/Discharge Petition H.Res. 102: Born-Alive Abortion Survivors Protection Act, and Discharge Petition; Affordable Care Act enforcement, Abortion separate payments; Enforcement of FDA Safety Requirements - abortion drugs; Bioethics issues; S. 160: Pain-Capable Unborn Child Protection Act.
Client expense: $160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4399/S.3072: Support and Value Moms and Babies Act; H.R. 1980: Women's History Museum; S. 2583: State and Foreign Operations Appropriations Act; Patients First Act; H.R. 3351: Financial Services and general Government Appropriations Act, 2020; H.R. 2500/S. 1790: National Defense Authorization Act for Fiscal Year 2020; H.R. 962/S. 130/Discharge Petition H.Res. 102: Born-Alive Abortion Survivors Protection Act, and Discharge Petition; Affordable Care Act enforcement, Abortion separate payments; H.R. 4934: Dignity for Aborted Children Act; H.J.Res. 79: Equal Rights Amendment; Organization of American State; Affordable Care Act enforcement; Enforcement of FDA Safety Requirements - abortion drugs; Bioethics issues; S.160: Pain-Capable Unborn Child Protection Act.
Client expense: $160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 962 Born-Alive Abortion Survivors Protection Act. . Provide protections for born-alive infants.
S. 2590 Dignity for Aborted Children Act. Protect dignity of fetal remains.
H.R. 4903 Down Syndrome Discrimination by Abortion Prohibition Act. Protect dignity of children with Down Syndrome.
S. 2745 Down Syndrome Discrimination by Abortion Prohibition Act. Protect dignity of children with Down Syndrome.
H.R. 4738 Pregnancy Discrimination Act. Provide work protections for pregnant women.
H.J. Res 79 Removing the Deadline for Equal Rights Amendment. Prevent ERA deadline from being removed.
H.R. 1980 Smithsonian Women's History Museum Act. Maintain political neutrality in Women's Museum.
H.R. 4399 Support and Value Expectant Moms and Babies Act. Increase FDA regulations on chemical abortion pills.
H.R. 4935 Teleabortion Prevention Act of 2019. Increase FDA regulations on chemical abortion pills.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 4399: Support and Value Moms and Babies Act; H.R. 3580/S. 2585: Ensuring Accurate & Complete Abortion Data Reporting Act; Patients First Act; H.R. 2740: Labor Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 2500/S. 1790: National Defense Authorization Act for Fiscal Year 2020; H.R. 962/S. 130/Discharge Petition H.Res. 102: Born-Alive Abortion Survivors Protection Act, and Discharge Petition; Affordable Care Act enforcement, Abortion separate payments; H.R. 437: Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act (Safe RESEARCH Act); Enforcement of FDA Safety Requirements - abortion drugs; H.R. 3877: Bipartisan Budget Act of 2019; Nondiscrimination in Health and Health Education Programs or Activities
Client expense: $200,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4399: Support and Value Moms and Babies Act; S. 2590: Dignity for Aborted Children Act; H.R. 1980: Women's History Museum; S. 2583: State and Foreign Operations Appropriations Act; Patients First Act; H.R. 2740: Labor Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 3351: Financial Services and general Government Appropriations Act, 2020; H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation and Housing and Urban Development Appropriations Act, 2020; H.R. 2500/S. 1790: National Defense Authorization Act for Fiscal Year 2020; H.R. 962/S. 130/Discharge Petition H.Res. 102: Born-Alive Abortion Survivors Protection Act, and Discharge Petition; Affordable Care Act enforcement, Abortion separate payments; H.R. 437: Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act (Safe RESEARCH Act); Enforcement of FDA Safety Requirements - abortion drugs; H.R. 573: Protecting Life and Integrity in Research Act of 2019; H.R. 2010: Second Chance at Life Act; H.R. 3877: Bipartisan Budget Act of 2019; Nondiscrimination in Health and Health Education Programs or Activities
Client expense: $200,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4399: Support and Value Moms and Babies Act; S. 2590: Dignity for Aborted Children Act; Patients First Act; H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation and Housing and Urban Development Appropriations Act, 2020; H.R. 437: Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act (Safe RESEARCH Act); Enforcement of FDA Safety Requirements - abortion drugs; H.R. 573: Protecting Life and Integrity in Research Act of 2019; H.R. 2010: Second Chance at Life Act
Client expense: $200,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 962 Born-Alive Abortion Survivors Protection Act. Provide protections for born-alive infants.
S. 311 Born-Alive Abortion Survivors Protection Act. Provide protections for born-alive infants.
S. 2590 Dignity for Aborted Children Act. Protect dignity of fetal remains.
S. 920 New Parents Act of 2019. Increase Paid Family Leave Options.
S. 160 Pain-Capable Unborn Child Protection Act. Prohibit late-term elective abortions after 20 weeks post-fertilization.
H.R. 4399 Support and Value Expectant Moms and Babies Act. Increase FDA Regulations on Abortion Pill.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), SENATE
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Client expense: $60,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office